Expression of Matrix Metalloproteinase (MMP)-2 and MMP-9 in Breast Cancer with a Special Reference to Activator Protein-2, HER2, and Prognosis

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Clinical Cancer Research

• Publication date

  2004-11-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-04-1061PMID 15569994
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TNM Classification of Malignant Tumours, 7th Edition

  2009cited by this paper
• Expression of HER2 and its association with AP-2 in breast cancer.

  2004cited by this paper
• Gelatinase A expression and localization in human breast cancers. An in situ hybridization study and immunohistochemical detection using confocal microscopy

  2004cited by this paper
• Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands

  2004influential reference
• Activator protein 2alpha inhibits tumorigenicity and represses vascular endothelial growth factor transcription in prostate cancer cells.

  2004cited by this paper
• Transcription Factors Pax6 and AP-2α Interact To Coordinate Corneal Epithelial Repair by Controlling Expression of Matrix Metalloproteinase Gelatinase B

  2004cited by this paper
• Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression.

  2004cited by this paper
• Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera

  2004cited by this paper
• Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN.

  2004cited by this paper
• MMP-2 Protein in Invasive Breast Cancer and the Impact of MMP-2/TIMP-2 Phenotype on Overall Survival

  2004cited by this paper
• Matrix Metalloproteinase-2 (MMP-2) is Associated with the Risk for a Relapse in Postmenopausal Patients with Node-Positive Breast Carcinoma Treated with Antiestrogen Adjuvant Therapy

  2004cited by this paper
• Activator Protein 2α Inhibits Tumorigenicity and Represses Vascular Endothelial Growth Factor Transcription in Prostate Cancer Cells

  2004cited by this paper
• Secreted MMP9 promotes angiogenesis more efficiently than constitutive active MMP9 bound to the tumor cell surface

  2004cited by this paper
• Expressions of Matrix Metalloproteinases in Early-Stage Oral Squamous Cell Carcinoma as Predictive Indicators for Tumor Metastases and Prognosis

  2004cited by this paper
• Overexpression of transcription factor AP-2alpha suppresses mammary gland growth and morphogenesis.

  2003cited by this paper
• Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation.

  2003cited by this paper
• Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma

  2003cited by this paper
• Cardiac neural crest contributes to cardiomyogenesis in zebrafish.

  2003cited by this paper
• Cloning and characterization of the mouse AP-2 epsilon gene: a novel family member expressed in the developing olfactory bulb.

  2003cited by this paper
• Molecular cloning and characterization of AP-2ε, a fifth member of the AP-2 family

  2003cited by this paper
• Regulation of extracellular matrix metalloproteinase inducer and matrix metalloproteinase expression by amphiregulin in transformed human breast epithelial cells.

  2003cited by this paper
• Activation of matrix metalloproteinase-2 and -9 by 2- and 4-hydroxyestradiol.

  2003cited by this paper
• Molecular cloning and characterization of AP-2 epsilon, a fifth member of the AP-2 family.

  2003cited by this paper
• Expression of proteinases and inhibitors in human breast cancer progression and survival

  2002cited by this paper
• New functions for the matrix metalloproteinases in cancer progression

  2002cited by this paper
• Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer.

  2002cited by this paper
• Increased MMP-2 Expression in Connective Tissue Growth Factor Over-expression Vascular Smooth Muscle Cells*

  2002cited by this paper
• A synthetic matrix metalloproteinase inhibitor prevents squamous carcinoma cell proliferation by interfering with epidermal growth factor receptor autocrine loops

  2002cited by this paper
• Estradiol upregulates mesangial cell MMP-2 activity via the transcription factor AP-2.

  2002cited by this paper
• Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice.

  2002cited by this paper
• Acceleration of invasive activity via matrix metalloproteinases by transfection of the estrogen receptor‐α gene in endometrial carcinoma cells

  2002cited by this paper
• Polymorphic catechol-O-methyltransferase gene and breast cancer risk.

  2001cited by this paper
• Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk.

  2001cited by this paper
• How matrix metalloproteinases regulate cell behavior.

  2001influential reference
• Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo

  2001cited by this paper
• Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer.

  2001cited by this paper
• Cloning and Characterization of a Novel Mouse AP-2 Transcription Factor, Ap-2δ, with Unique DNA Binding and Transactivation Properties*

  2001cited by this paper
• Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negativeatients

  2001influential reference
• Proteolysis in human breast cancer

  2000cited by this paper
• Gelatinase A, Membrane Type 1 Matrix Metalloproteinase, and Extracellular Matrix Metalloproteinase Inducer mRNA Expression: Correlation with Invasive Growth of Breast Cancer

  2000cited by this paper
• Steroid metabolism gene CYP17 polymorphism and the development of breast cancer.

  2000cited by this paper
• Expression and regulation of c‐erbB ligands in human head and neck squamous carcinoma cells

  2000cited by this paper
• Expression of MMP‐2 and MMP‐9, their inhibitors, and the activator MT1‐MMP in primary breast carcinomas

  1999influential reference
• MMP-2 positivity and age less than 40 years increases the risk for recurrence in premenopausal patients with node-positive breast carcinoma

  1999cited by this paper
• Immunohistochemical analysis reveals a tumour suppressor‐like role for the transcription factor AP‐2 in invasive breast cancer

  1999cited by this paper
• The Transcription Factors Sp1, Sp3, and AP-2 Are Required for Constitutive Matrix Metalloproteinase-2 Gene Expression in Astroglioma Cells*

  1999cited by this paper
• Proteolysis in human breast and colorectal cancer

  1999cited by this paper
• Matrix-metalloproteinases 1, 2 and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: an in situ hybridization study

  1999cited by this paper
• Tissue distribution of major matrix metalloproteinases and their transcripts in human breast carcinomas.

  1999cited by this paper
• Selection of potentially metastatic subpopulations expressing c-erbB-2 from breast cancer tissue by use of an extravasation model.

  1998cited by this paper
• A Synergistic Interaction of Transcription Factors AP2 and YB-1 Regulates Gelatinase A Enhancer-dependent Transcription*

  1998cited by this paper
• Prognostic significance of stromelysin 3, gelatinase A, and urokinase expression in breast cancer.

  1998cited by this paper
• Expression of gelatinases A and B, stromelysin-3 and matrilysin genes in breast carcinomas: clinico-pathological correlations

  1998cited by this paper
• Overexpression of EGFR and c‐erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts

  1998cited by this paper
• Matrix metalloproteinase‐2 immunoreactive protein

  1998cited by this paper
• Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer.

  1998cited by this paper
• Expression of matrix metalloprotease-9 in vascular pericytes in human breast cancer.

  1997cited by this paper
• Transcriptional activity of the human tissue inhibitor of metalloproteinases 1 (TIMP-1) gene in fibroblasts involves elements in the promoter, exon 1 and intron 1.

  1997cited by this paper
• Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis.

  1997influential reference
• Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.

  1997cited by this paper
• A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma.

  1996cited by this paper
• Repression of a matrix metalloprotease gene by E1A correlates with its ability to bind to cell type-specific transcription factor AP-2.

  1996cited by this paper
• Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response.

  1996cited by this paper
• Steps Involved in Activation of the Pro-matrix Metalloproteinase 9 (Progelatinase B)-Tissue Inhibitor of Metalloproteinases-1 Complex by 4-Aminophenylmercuric Acetate and Proteinases (*)

  1995cited by this paper
• c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties.

  1994cited by this paper
• The rabbit gene for 92-kDa matrix metalloproteinase. Role of AP1 and AP2 in cell type-specific transcription.

  1994cited by this paper
• Enhanced expression of tissue inhibitor of metalloproteinase‐2 (TIMP‐2) in the stroma of breast carcinomas correlates with tumor recurrence

  1994cited by this paper
• 72 KD and 92 KD type IV collagenase, type IV collagen, and laminin mRNAs in breast cancer: a study by in situ hybridization.

  1994cited by this paper
• Activity of type IV collagenases in benign and malignant breast disease.

  1993cited by this paper
• Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin.

  1992cited by this paper
• Genes involved in tumor invasion and metastasis are differentially modulated by estradiol and progestin in human breast‐cancer cells

  1992cited by this paper
• Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells.

  1991cited by this paper
• Positive and negative transcriptional elements of the human type IV collagenase gene

  1990cited by this paper
• Structure of the human type IV collagenase gene.

  1990cited by this paper
• Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2.

  1989cited by this paper
• Differential regulation of growth and invasiveness of MCF-7 breast cancer cells by antiestrogens.

  1988cited by this paper
• Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

  1987cited by this paper

• Therapeutic potential of inhibitors of gelatinases MMP-2 and MMP-9 for the treatment of breast cancer.

  2025cites this paper
• Linoleic acid induces migration and invasion through TLR4 in breast cancer cells.

  2025cites this paper
• Progress in the antitumor molecular mechanisms of Isorhamnetin

  2025cites this paper
• Cannabinoid Receptor Type 2 Agonist, GW405833, Reduced the Impacts of MDA‐MB‐231 Breast Cancer Cells on Bone Cells

  2025cites this paper
• MMP2 rs243865 and MMP8 rs11225395 Gene Polymorphisms Are Correlated With Breast Cancer Risk in Bangladeshi Women: Evidence From a Case-Control Study

  2025cites this paper
• LMAN2 interacts with HEATR3 to expedite HER2-positive breast cancer advancement and inflammation and Akt/ERK/NF-κB signaling.

  2025cites this paper
• Molecular Dynamics of Breast Cancer Subtypes: The Role of FAM83H-AS1 Long Non-coding RNA in Breast Cancer Metastasis

  2025cites this paper
• Evaluation of the clinical efficacy of Ru’ai Shuhou recipe for the prevention of lung metastases from breast cancer: a retrospective study based on propensity score matching

  2024cites this paper
• 髓源性抑制细胞是乳腺癌进展的潜在因素和重要靶点

  2024cites this paper
• Estrogen Sulfotransferase (SULT1E1) and NFκβ Confer Matrix Metalloprotease (MMP 2/9) Action in Breast Carcinogenesis

  2024cites this paper
• Deregulation of MMP-2 and MMP-9 in laryngeal cancer: A retrospective observational study

  2024cites this paper
• Biomaterials to regulate tumor extracellular matrix in immunotherapy.

  2024cites this paper
• Targeted drug delivery systems for matrix metalloproteinase-responsive anoparticles in tumor cells: A review.

  2023cites this paper
• miR‑151a‑5p promotes the proliferation and metastasis of colorectal carcinoma cells by targeting AGMAT

  2023cites this paper
• Matrix metalloproteinases as therapeutic targets in breast cancer

  2023cites this paper
• Fibronectin-targeting and metalloproteinase-activatable smart imaging probe for fluorescence imaging and image-guided surgery of breast cancer

  2023cites this paper
• Role and Application of Biocatalysts in Cancer Drug Discovery

  2023cites this paper
• An electrochemical biosensor to identify the phenotype of aggressive breast cancer cells.

  2023cites this paper
• Epithelial-mesenchymal Transition Factor and Its Association With Mammographic Density and Breast Cancer Prognosis

  2023cites this paper
• Comparison of MMP-9 Density Between Triple Negative and HER2 Enriched Breast Carcinoma Subtypes

  2023cites this paper
• The Effect of Encapsulated Apigenin Nanoparticles on HePG-2 Cells through Regulation of P53

  2022cites this paper
• Immune-Related Gene Signatures to Predict the Effectiveness of Chemoimmunotherapy in Triple-Negative Breast Cancer Using Exploratory Subgroup Discovery

  2022cites this paper
• The risk of relapse in breast cancer patients is associated with MMP-9 gene polymorphism: a prospective study in a sample of the Iranian population

  2022influential citation
• Effects of thiostrepton alone or in combination with selumetinib on triple-negative breast cancer metastasis

  2022cites this paper
• Quercetin - Based Rhodium(III) Complex: Synthesis, Characterization and Diverse Biological Potentials

  2022cites this paper
• Resistance to Trastuzumab

  2022cites this paper
• Nanomodulation and nanotherapeutics of tumor-microenvironment

  2022cites this paper
• Advances in peptide drug conjugate-based supramolecular hydrogel systems for local drug delivery

  2022cites this paper
• A thermo-sensitive hydrogel composed of methylcellulose/hyaluronic acid/silk fibrin as a biomimetic extracellular matrix to simulate breast cancer malignancy

  2022cites this paper
• Metabolic Intervention Nanoparticles for Triple‐Negative Breast Cancer Therapy via Overcoming FSP1‐Mediated Ferroptosis Resistance

  2022cites this paper
• Diagnostic and prognostic values of MMP-9 expression in ovarian cancer: A study based on bioinformatics analysis and meta-analysis

  2022cites this paper
• Onosma L. as a source of anticancer agents: phytochemistry to mechanistic insight

  2022cites this paper
• The effect of obesity on adipose-derived stromal cells and adipose tissue and their impact on cancer

  2022cites this paper
• Peptide-Based Strategies for Targeted Tumor Treatment and Imaging

  2021cites this paper
• Dichotomy in Growth and Invasion from Low- to High-Grade Glioma Cellular Variants

  2021cites this paper
• Study of the Relationship between MMP-2 and MMP-9 and Her2/neu Overexpression in Gastric Cancer: Clinico-Pathological Correlations

  2021cites this paper
• The relationship of tumor microenvironment and clinico-pathological parameters in different molecular subtypes of breast cancer

  2021cites this paper
• Relationship between matrix metalloproteinase-9 and some clinicopathological prognostic factors of breast carcinoma.

  2021influential citation
• Cancer‐associated fibroblasts induce an aggressive phenotypic shift in non‐malignant breast epithelial cells via interleukin‐8 and S100A8

  2021cites this paper
• Global Protease Activity Profiling Identifies HER2-Driven Proteolysis in Breast Cancer.

  2021cites this paper
• MMP9 EXPRESSION IN THE CYTOPLASM OF SURROUNDING STROMAL CELLS OF BREAST CARCINOMA IN RELATION TO PATHOLOGICAL STAGE, GRADE AND RECEPTOR STATUS

  2021cites this paper
• Four Matrix Metalloproteinase genes involved in murine breast cancer affected by ginger extract

  2021cites this paper
• Exposure to water-pipe smoking dysregulates a set of genes associated with breast cancer development and an unfavorable outcome

  2021cites this paper
• TNF-α Increases IP-10 Expression in MCF-7 Breast Cancer Cells via Activation of the JNK/c-Jun Pathways

  2021cites this paper
• Proteomic profiling of milk small extracellular vesicles from bovine leukemia virus-infected cattle

  2021cites this paper
• Contradictory Effect of Notch1 and Notch2 on Phosphatase and Tensin Homolog and its Influence on Glioblastoma Angiogenesis

  2021cites this paper
• The Association of MMP9 Promoter Rs3918242 Genotype With Gastric Cancer

  2021cites this paper
• Metalloproteinases 1 and 3 as Potential Biomarkers in Breast Cancer Development

  2021cites this paper
• Therapeutic supramolecular tubustecan hydrogel combined with checkpoint inhibitor elicits immunity to combat cancer.

  2021cites this paper
• Oxidative, Inflammatory, Angiogenic Markers and Vitamin D Status in Pre- and Postmenopausal Breast Cancer Egyptian Patients

  2021cites this paper
• MiR-146a Restoration Suppresses Triple-Negative Breast Cancer Cell Migration: A Bioinformatic and In Vitro Study

  2021cites this paper
• BCTT_A_305387 271..283

  2021cites this paper
• Cysteine Cathepsins and Matrix Metalloproteases Among Breast Cancer Patients

  2021cites this paper
• Clinical and prognostic features of MMP-2 and VEGF in AEG patients

  2021cites this paper
• Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: a systematic review and meta-analysis

  2021cites this paper
• A Single Nucleotide Polymorphism in the MMP9 Promoter Affects Lung Cancer and Clinicopathological Properties in Iranian Population

  2021cites this paper
• The role of molecular markers of angiogenesis in disease prediction in breast cancer patients

  2020cites this paper
• Effect of black grape extract on MMP-9 gene expression in breast cancer cells

  2020cites this paper
• The indirect antiangiogenic effect of IL‐37 in the tumor microenvironment

  2020cites this paper
• Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival

  2020cites this paper
• 15d-PGJ2 inhibits NF-κB and AP-1-mediated MMP-9 expression and invasion of breast cancer cell by means of a heme oxygenase-1-dependent mechanism

  2020cites this paper
• Impact of metastatic prostate cancer on human bone marrow

  2020cites this paper
• Triad entanglement of estrogen-sulfotransferase (SULT1E1), NFκβ and Nrf-2 confers matrix-metalloprotease (MMP 2/9) action in breast carcinogenesis.

  2020cites this paper
• Prognostic role of matrix metalloproteinase 9 in early breast cancer

  2020cites this paper
• Recent advances in the development of activatable multifunctional probes for in vivo imaging of caspase-3

  2020cites this paper
• Overview of the Anticancer Potential of the “King of Spices” Piper nigrum and Its Main Constituent Piperine

  2020cites this paper
• Analysis of the Gene Expression Profile of Stromal Pro-Tumor Factors in Cancer-Associated Fibroblasts from Luminal Breast Carcinomas

  2020cites this paper
• Nanomedicine and chemotherapeutics drug delivery: challenges and opportunities

  2020cites this paper
• Neutrophils in the Tumor Microenvironment.

  2020cites this paper
• Aged Breast Extracellular Matrix Drives Mammary Epithelial Cells to an Invasive and Cancer‐Like Phenotype

  2020cites this paper
• Intraepithelial matrix metalloproteinase-9 in invasive breast carcinoma, normal tissue adjacent to tumor, and normal mammoplasty specimens: a comparative study considering relationship between matrix metalloproteinase-9 and some clinicopathologic prognostic factors of breast carcinoma

  2020cites this paper
• Contribution of Matrix Metalloproteinase-9 rs3918242 Genotypes to Childhood Leukemia Risk

  2020cites this paper
• Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment

  2020cites this paper
• A Bioinformatics Research on Novel Mechanism of Compound Kushen Injection for Treating Breast Cancer by Network Pharmacology and Molecular Docking Verification

  2020cites this paper
• Immunoexpression of metalloproteinases 9 (MMP-9) and 2 (MMP-2) and their inhibitors (TIMP-1 and TIMP-2) in normal and neoplastic canine mammary tissue

  2020influential citation
• The standard form of CD44 as a marker for invasion of encapsulated papillary carcinoma of the breast

  2020cites this paper
• Tumor‐Targeting Glycol Chitosan Nanoparticles for Cancer Heterogeneity

  2020cites this paper
• Anti-EMT properties of CoQ0 attributed to PI3K/AKT/NFKB/MMP-9 signaling pathway through ROS-mediated apoptosis

  2019cites this paper
• Diagnostic power of VEGF, MMP-9 and TIMP-1 in patients with breast cancer. A multivariate statistical analysis with ROC curve.

  2019cites this paper
• Tumor-Associated Neutrophils in Cancer: Going Pro

  2019cites this paper
• Predicted Markers of Overall Survival in Pancreatic Cancer Patients Receiving Dendritic Cell Vaccinations Targeting WT1

  2019cites this paper
• OTT_A_202280 5701..5711

  2019cites this paper
• Theranostic Layer-by-Layer Nanoparticles for Simultaneous Tumor Detection and Gene Silencing.

  2019cites this paper
• Association of Matrix Metalloproteinase-9 rs3918242 Promoter Genotypes With Colorectal Cancer Risk

  2019cites this paper
• Clinical significance of plasma MMP‐2 and MMP‐9 levels as biomarkers for tumor expression in breast cancer patients in Egypt

  2019cites this paper
• Monoclonal anti-MUC1 antibody with novel octahydropyrazino[2,1-a:5,4-a′]diisoquinoline derivative as a potential multi-targeted strategy in MCF-7 breast cancer cells

  2019cites this paper
• Dynamic supraparticles for the treatment of age-related diseases.

  2019cites this paper
• Quantitative expression of MMPs 2, 9, 14, and collagen IV in LCIS and paired normal breast tissue

  2019cites this paper
• Seeking for Correlative Genes and Signaling Pathways With Bone Metastasis From Breast Cancer by Integrated Analysis

  2019cites this paper
• Ginsenoside Rh2 Ameliorates Doxorubicin-Induced Senescence Bystander Effect in Breast Carcinoma Cell MDA-MB-231 and Normal Epithelial Cell MCF-10A

  2019cites this paper
• Diagnostic Power of Cytokine M-CSF, Metalloproteinase 2 (MMP-2) and Tissue Inhibitor-2 (TIMP-2) in Cervical Cancer Patients Based on ROC Analysis

  2019cites this paper
• The Difference of Expression of 18 Genes in Axillary Invasion and Vascular Invasion Compared to Control Samples in Breast Cancer

  2019influential citation
• Effect of MMP-2 gene silencing on radiation-induced DNA damage in human normal dermal fibroblasts and breast cancer cells

  2019cites this paper
• Factors affecting aggressive oral tongue cancer invasion and development of in vitro models for chemoradiotherapy assay

  2019cites this paper
• Heme Oxygenase-1 Has an Antitumor Role in Breast Cancer

  2019cites this paper
• A Review on Matrix Metallo Proteinases-9 (MMP-9) and Cancer Progression: Focusing Molecular Insights of MMP-9 Activation Signaling Pathways and Role in Breast Cancer and Esophageal

  2019cites this paper
• Bioconjugation of Cyclometalated Gold(III) Lipoic Acid Fragments to Linear and Cyclic Breast Cancer Targeting Peptides.

  2019cites this paper
• An Au-Se nanoprobe for the evaluation of the invasive potential of breast cancer cells via imaging the sequential activation of uPA and MMP-2.

  2019cites this paper
• Matrix metalloproteinase 2 contributes to aggressive phenotype, epithelial-mesenchymal transition and poor outcome in nasopharyngeal carcinoma

  2019cites this paper
• Combinatorial engineering of N-TIMP2 variants that selectively inhibit MMP9 and MMP14 function in the cell

  2018cites this paper